0001493152-20-000170.txt : 20200103 0001493152-20-000170.hdr.sgml : 20200103 20200103210544 ACCESSION NUMBER: 0001493152-20-000170 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200101 FILED AS OF DATE: 20200103 DATE AS OF CHANGE: 20200103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GLECKEL LOUIS MD CENTRAL INDEX KEY: 0001164762 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21617 FILM NUMBER: 20507896 MAIL ADDRESS: STREET 1: C/O PROHEALTH CARE ASSOCIATES LLP STREET 2: 2800 METRUS AVE CITY: LAKE SUCCESS STATE: NY ZIP: 11042 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ProPhase Labs, Inc. CENTRAL INDEX KEY: 0000868278 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232577138 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 621 N. SHADY RETREAT ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 BUSINESS PHONE: 2153450919 MAIL ADDRESS: STREET 1: 621 N. SHADY RETREAT ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 FORMER COMPANY: FORMER CONFORMED NAME: QUIGLEY CORP DATE OF NAME CHANGE: 19930328 4 1 ownership.xml X0306 4 2020-01-01 0 0000868278 ProPhase Labs, Inc. PRPH 0001164762 GLECKEL LOUIS MD 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 1 0 0 0 Common Stock, par value $0.0005 2020-01-01 4 A 0 5564 2.02 A 109894 D These shares of common stock were issued under the 2010 Directors' Equity Compensation Plan, as amended, pursuant to an election by the Reporting Person to receive shares of common stock of the Issuer in lieu of a cash payment for quarterly director fees. /s/ Louis Gleckel, MD 2020-01-03